Urinalysis Market worth $4.9 billion by 2026
Urinalysis Market is projected to reach USD 4.9 billion by 2026, at a 7.2% CAGR according to a new report by MarketsandMarkets™. The increasing burden of UTIs, diabetes, and kidney & liver diseases; rising geriatric population and the subsequent increase in age-associated diseases and increasing adoption of POC diagnostic tests are factors supporting the growth of this market. Growth opportunities in emerging economies provide lucrative opportunities for the players operating in the urinalysis market.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=153479294
Browse in-depth TOC on "Urinalysis Market"
229 - Tables
44 - Figures
243 – Pages
Urinalysis Market Scope:
|
Report Coverage |
Details |
|
Market Size |
USD 4.9 billion by 2026 |
|
Growth Rate |
7.2% of CAGR |
|
Largest Market |
North America |
|
Market Dynamics |
Drivers, Restraints, Opportunities & Challenges |
|
Forecast Period |
2021-2026 |
|
Forecast Units |
Value (USD Billion) |
|
Report Coverage |
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
|
Segments Covered |
Product, test type, application, end user, and region |
|
Geographies Covered |
North America, Europe, Asia Pacific, and Rest of the World |
|
Report Highlights |
Updated financial information / product portfolio of players |
|
Key Market Opportunities |
Growth opportunities for urinalysis in growing economies |
|
Key Market Drivers |
Rising geriatric population and the subsequent increase in age-associated diseases |
The consumables segment accounted for the largest share of urinalysis market, by product segment
Based on product, the urinalysis market is segmented into consumables and instruments. The consumables segment accounted for the largest share of this market. The frequent purchase of these products due to their recurrent usage drives the market growth of this segment.
Sediment urinalysis segment to register the highest CAGR during the forecast period
Based on the test type, the urinalysis market has been segmented into pregnancy & fertility tests, biochemical urinalysis and sediment urinalysis. The sediment urinalysis segment accounted for the highest CAGR. This can be primarily attributed to the increasing adoption of automated devices for sediment analysis.
The disease screening segment accounted for the largest share of the urinalysis market, by application segment
Based on application, the urinalysis market is segmented into disease screening and pregnancy & fertility. The disease screening segment accounted for the largest share of this market. Factors such as the increasing incidence of UTIs, diabetes, liver diseases and kidney ailments worldwide are driving the growth of this market.
The diagnostic laboratories segment accounted for the largest share of urinalysis market, by end user segment
Based on end user, the urinalysis market has been segmented into diagnostic laboratories, hospitals and clinics, home care settings and research laboratories & institutes. Diagnostic laboratories accounted for the largest share of the urinalysis market. Diagnostic laboratories command the major share of the urinalysis market owing to rapidly growing aging population, the increasing global incidence of kidney diseases and UTIs, increase in reimbursements for clinical tests performed in hospitals, and the launch of advanced urinalysis devices such as integrated devices.
North America is the largest regional market for urinalysis market
The urinalysis market is segmented into five regions, namely, North America, Europe, Asia Pacific, and Rest of the World. North America accounted for the largest share of the urinalysis market. The large share of this region can be attributed to growing geriatric population, implementation of favourable government initiatives, increasing healthcare expenditure, improved healthcare infrastructure, and the availability of technologically advanced instruments
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=153479294
Urinalysis Market Dynamics:
Drivers:
- Increasing burden of UTIs, diabetes, and liver & kidney diseases
- Rising geriatric population and the subsequent increase in age-associated diseases
- Increasing adoption of POC urine diagnostic tests
Restraints:
- Availability of refurbished urine analyzers
Opportunities:
- Emerging economies
- Technological advancements in urine analyzers
Challenges:
- Changing regulatory landscape for the
Key Market Players:
The major players operating in urinalysis market are Siemens Healthineers AG (Germany), F. Hoffmann-La Roche Ltd. (Switzerland), Cardinal Health, Inc. (US), Abbott Laboratories (US), Danaher Corporation (US), Sysmex Corporation (Japan), Quidel Corporation (US), Becton, Dickinson and Company (US), Bio-Rad Laboratories, Inc. (US), EKF Diagnostics (UK), Thermo Fisher Scientific Inc. (US), ARKRAY, Inc. (Japan).
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian